IL18 and neoplasm: Downstream of inflammasome and GSDMD activation, IL-1β and IL-18 can also have a beneficial effect as they play a pivotal role in the activation of dendritic and natural killer (NK) cells, respectively, and can, thereby, promote anti-tumor immune responses.